Abstract:Mixed-valence (MV) binuclear ferrocenyl compounds have long been studied as models for testing theories of electron transfer and in attempts to design molecular-scale electronic devices (e.g., molecular wires). In contrary to that, far less attention has been paid to MV binuclear ferrocenes as anticancer agents. Herein, we discuss the synthesis of six 1,2,3-triazole ferrocenyl compounds for combined (spectro)electrochemical, electron paramagnetic resonance (EPR), computational, and anticancer activity studies. Our synthetic approach was based on the copper-catalyzed 1,3-dipolar azide-alkyne cycloaddition reaction and enabled us to obtain in one step compounds bearing either one, two, or three ferrocenyl entities linked to the common 1,2,3-triazole core. Thus, two series of complexes were obtained, which pertain to derivatives of 3'-azido-3'-deoxythymidine (AZT) and 3-azidopropionylferrocene, respectively. Based on the experimental and theoretical data, the two mono-oxidized species corresponding to binuclear AZT and trinuclear 3-azidopropionylferrocene complexes have been categorized as class II mixed-valence according to the classification proposed by Robin and Day. Of importance is the observation that these two compounds are more active against human A549 and H1975 non-small-cell lung cancer cells than their congeners, which do not show MV characteristics. Moreover, the anticancer activity of MV species competes or surpasses, dependent on the cell line, the activity of reference anticancer drugs such as cisplatin, tamoxifen, and 5-fluorouracil. The most active from the entire series of compounds was the binuclear thymidine derivative with the lowest IC50 value of 5 ± 2 μM against lung H1975 cancer cells. The major mechanism of antiproliferative activity for the investigated MV compounds is based on reactive oxygen species generation in cancer cells. This hypothesis was substantiated by EPR spin-trapping experiments and the observation of decreased anticancer activity in the presence of N-acetyl cysteine (NAC) free-radical scavenger.

Novel ferrocene cyclopalladated compounds: Synthesis, and in‐vitro antitumor activity study

New ferrocene cyclopalladated compounds: synthesis, X-ray single crystal structure and in vitro anticancer activity study

A novel ferrocene-palladium metal complex: synthesis, single crystal structure, in vitro cytotoxicity study and molecular docking

Assessment of the Antitumor Activity of a Cyclopalladated Ferrocene Compound Assisted by a Dual-Targeting Drug Delivery System

Organometallic Binuclear Pd(II) Complex: Synthesis, Crystal Structure and In-Vitro Antitumor Activity Study

Structures and antitumor activities of planar chiral cyclopalladated ferrocene derivatives

Ferrocene-modified Half-Sandwich Iridium(iii) and Ruthenium(ii) Propionylhydrazone Complexes and Anticancer Application

Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research.

Anticancer Application of Ferrocene Appended Configuration-Regulated Half-Sandwich Iridium(iii) Pyridine Complexes

Ferrocenyl β‐Diketonate Compounds: Extended Ring Systems for Improved Anticancer Activity

Synthesis and Evaluation of Novel Ferrocenyl Thiazole Derivatives as Anticancer Agents

New Potential Anticancer Agent Of Carborane Derivatives: Selective Cellular Interaction And Activity Of Ferrocene-Substituted Dithio-O-Carborane Conjugates

Electronic Coupling in 1,2,3-Triazole Bridged Ferrocenes and Its Impact on Reactive Oxygen Species Generation and Deleterious Activity in Cancer Cells

Diversity-oriented synthesis and bioactivity evaluation of N-substituted ferrocifen compounds as novel antiproliferative agents against TNBC cancer cells

Organometallic Antitumor Compounds: Ferrocifens As Precursors to Quinone Methides

The Anticancer Application of Half-Sandwich Iridium(iii) Ferrocene-Thiosemicarbazide Schiff Base Complexes.

Syntheses and in Vitro Antitumor Activities of Ferrocene-Conjugated Arg-Gly-Asp Peptides

Electrochemical studies and potential anticancer activity in ferrocene derivatives

Configurationally regulated half-sandwich iridium(III)-ferrocene heteronuclear metal complexes: Potential anticancer agents

Synthesis and Antiproliferative Evaluation of Novel Hydroxypropyl-Ferrociphenol Derivatives, Resulting from the Modification of Hydroxyl Groups

Synthesis and Biological Evaluation of Novel Furopyridone Derivatives as Potent Cytotoxic Agents against Esophageal Cancer